Bivalirudin vs. heparin on a background of ticagrelor and aspirin in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A multicenter prospective cohort study.

Front Cardiovasc Med · 2022 · PMC9649932 · PMID 36386368

Europe PMC DOI

hedged sentence

0.7670

closest p · 15.3× alpha

0.7670

boldest claim

The sentences

did not reach statistical significanceP = 0.767not close (p > 0.1)

The difference did not reach statistical significance ( P = 0.767).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.